AdComconf 0.85

imetelstat — AdCom

$GERN · GERON CORP · transfusion-dependent anemia in adult patients with low- to intermediate-1 risk myelodysplastic syndromes who have failed to respond, or have lost response to, or are ineligible for erythropoiesis-stimulating agents

Event date

Date TBD

Sponsor runway

3 mo

$68.9M liquid

Evidence

“the FDA informed the Company that it is currently planning to hold an advisory committee meeting as part of the NDA review”

Source: 8-K filed 2023-08-22View on EDGAR ↗0000950170-23-043949

Comparable historical adcoms· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

4 insiders · 0 buys · 0 sells

Grant

2026-04-13

Williams Timothy

EVP and Chief Legal Officer

2,500,000 @ ——

Grant

2026-03-31

Spiegel Robert J.

Director

5,243 @ $1.49$8K

Grant

2026-03-25

Chinoporos Constantine

Director

270,000 @ ——

Grant

2026-03-25

Andrews Patricia S

Director

270,000 @ ——

Date	Insider	Action	Shares	Price	Value
2026-04-13	Williams TimothyEVP and Chief Legal Officer	Grant	2,500,000	—	—
2026-03-31	Spiegel Robert J.Director	Grant	5,243	$1.49	$8K
2026-03-25	Chinoporos ConstantineDirector	Grant	270,000	—	—
2026-03-25	Andrews Patricia SDirector	Grant	270,000	—	—

← All catalysts for $GERN